StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research note released on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. XBiotech Stock Performance XBiotech stock opened at $5.00 on Thursday. The stock has a market capitalization of $152.20 million, a price-to-earnings ratio of -4.20 and […]